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Abstract
HOX genes are a group of evolutionarily conserved genes that encode a family 
of transcription factors that regulate early developmental morphogenetic processes 
and continue to be expressed into adulthood. These highly conserved HOX factors 
play an unquestioned crucial role as master regulators during embryonic vertebrate 
development and morphogenesis by controlling the three dimensional body plan 
organization. HOX genes specify regions of the body plan of an embryo along 
the head-tail axis. They encode proteins that specify the characteristics of ‘posi-
tion’, ensuring that the correct structures form in the correct places of the body. 
Expression of HOX is known to persist in many tissues in the postnatal period 
suggesting the role of these genes not only during development but also for the 
functioning of tissues throughout life. The tissue-specific pattern of HOX gene 
expression is inherent in stromal/stem cells of mesenchymal origin, such as mesen-
chymal stromal cells, fibroblasts, smooth muscle cells, and preadipocytes, enabling 
them to memorize their topographic location in the form of their HOX code and to 
fulfill their location-specific functions. In this chapter, we focus on the expression 
and potential role of HOX genes in adult tissues. We review evidence that site-
specific expression of HOX genes is connected to location-specific disease suscep-
tibility and review studies showing that dysregulated expression of HOX genes can 
be associated with various diseases. By recognizing the importance of site-specific 
molecular mechanisms in the organ stroma, we gain new insights into the processes 
underlying the site-specific manifestation of disease.
Keywords: Fibroblasts, HOX genes, site-specific gene expression, embryonic 
development, disease locations
1. Introduction
In vertebrate animals, the stromal compartment of organs is composed of 
extracellular matrix and mesenchymal cells. Fibroblasts are one of the most abun-
dant and principal stromal cell types and have a variety of vital, locally specialized 
functions in tissue repair and homeostasis. Primarily, they are the main source of 
extracellular matrix (ECM) proteins, which, in addition to providing a structural 
scaffold for cells, play critical roles in determining cell phenotype and function. 
Fibroblasts produce and secrete all components of the ECM, including structural 
proteins, adhesive proteins, and a space-filling ground substance composed of 
glycosaminoglycans and proteoglycans [1].
Furthermore, as a result of their reciprocal interaction with epithelial cells, 
fibroblast cells play an important role during development and morphogenesis of 
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tissues and organs including the skin, eyes, lung and other visceral organs. The 
organ stroma provides a structural framework and guidance for blood and lym-
phatic vessels, nerves and leukocytes and is critically involved in the regulation of 
physiological organ function.
During stress, fibroblasts respond by sending signals to help the surrounding 
tissue to adapt to changes in the environment [2]. The phenotype of fibroblast 
can transform and provides the necessary components to replace wounded tissue. 
During pathologic states, however, ECM can be generated in excessive quantities, 
leading to irreversible organ dysfunction caused by collagen deposition in a  
dysregulated manner [3].
Given the wide variations of gene expression and strikingly different responses 
to extracellular signals among fibroblasts from different organs, these fibroblast 
populations should be considered as distinct cell types. Human fibroblasts 
obtained from vocal fold, trachea, lung, abdomen, scalp, upper gingiva, and soft 
palate, displayed a phenomenon of global topographic differentiation across all 
anatomic site domains with the specialized genotype of the vocal fold fibroblast 
uniquely characterized to achieve homeostasis under complex mechanobiological 
requirements [4].
During development of multicellular organisms, developmental control genes 
are critical for pattern formation and cell fate specification in specific spatiotempo-
ral patterns [5]. Most of these genes encode transcription factors acting in cascades 
and networks, regulating the expression of further developmental control genes 
and ultimately organ-specific ‘effector’ genes, which control patterning, morpho-
genesis and differentiation of tissue-specific functions and specific body parts [6]. 
The wide range of organ specific differences in fibroblast function is complemented 
by distinct and characteristic gene expression patterns depending on their anatomic 
site of origin [7]. Examples include HOX genes, which can lead to the transforma-
tion of specific body segments when mutated [8], Pax6, which controls eye develop-
ment [9] and MyoD, which is crucial for muscle formation [10].
Functional diversity of fibroblasts is not only important during embryonic 
developmental and physiologic specialization of many tissues, but might also influ-
ence site- and organ-specific differences in the susceptibility of different tissues to 
disease development [11, 12].
2. Site-specific regulation of gene expression by HOX genes
Spatial organization of cellular differentiation is achieved by a unique local 
developmental specification of cell types. This can be reinforced by the cells’ 
interpretation of environmental signals specific to their position in the body. HOX 
genes are known to be master regulators of body pattern formation during embryo-
genesis, activating other genes to specify positional identities in development.
In humans, there are 39 HOX genes organized into 4 distinct clusters. The 4 
clusters map to 4 different chromosomes and contain between 9 and 11 genes. These 
clusters, labeled HOXA, HOXB, HOXC and HOXD, are located on chromosomes 
7p14, 17q21, 12q13 and 2q31, respectively [13, 14]. HOX proteins are transcription 
factors that are bound by different protein cofactors. The analysis of HOX protein 
binding activity showed that the homeodomain, a highly conserved 60 amino acid 
helix-turn-helix motif, is a DNA-binding protein that recognize AT rich short DNA 
motifs, often with a core of TAAT [15]. In several cases, functional specificity of the 
different HOX proteins could be attributed to the homeodomain itself [16, 17]. The 
homeodomains showed distinct protein- and/or DNA-binding activities, suggesting 
that variation in sequence recognition may be a factor in their functional diversity.
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In vertebrates, the different sets of HOX genes are expressed in parallel [15]. 
Thus, site- and/or organ-specific fibroblast phenotypes are shaped by a combinato-
rial expression of genes from the four HOX clusters. Genome-wide gene expression 
profile of 47 fibroblast populations from 43 anatomic sites spanning the human 
body, including arm, leg, trunk, foreskin and internal organs, analyzed by unsu-
pervised hierarchical clustering revealed a specific code of HOX genes according 
to their position in the human body. Fibroblasts from the same topographic site, 
independent from which organ they were isolated, expressed the same, site-
specific, unique “HOX-code”, which resulted in grouping of the cells from the same 
site together, based solely on the expression pattern of the HOX genes. This suggests 
that the expression of a specific set of HOX genes is connected to the cells’ location 
in the body, potentially conferring important site-specific functions needed in a 
particular location [18].
Thus, site-specific variations in the gene expression programs of fibroblasts are 
not random but are systematically related to their positional identities along the 
major anatomical axes, which are formed during embryogenesis.
3. The role of HOX genes in embryonic development
In many animals, especially vertebrates, various HOX gene paralogues are 
located genetically close to each other in clusters [19]. The order of the genes on the 
chromosome corresponds to the expression of the genes in the developing embryo 
[14, 20, 21]. Thereby, the genes in the 5′ genetic locus are expressed in the anterior 
end or distal parts of the developing organism and the genes in the 3′ locus are 
expressed in the posterior end or proximal parts - a phenomenon known as spatial 
colinearity [22]. In addition, there is a temporal sequence of activation of HOX 
genes in vertebrate. 5′ genes are expressed later, whereas 3′ genes are expressed 
earlier in embryonic development [18, 19]. The unique orderly arrangement of 
the genes in the genome is related to the activation of HOX genes in a temporal 
sequence by gradual unpacking of chromatin along a gene cluster, thereby control-
ling the expression of the right HOX gene at the right location at the right time in 
embryogenesis [23]. The temporal and spatial tightly controlled expression of HOX 
genes in mesenchymal cells can thus explain how genetic information is translated 
to the spatial organization of various cells in the body (Figure 1).
Over the past years, gain-of-function and loss-of-function approaches in chick 
and mice together with studies of mutations, indicated the essential role of HOX 
genes in proper vertebrate limb growth and organization of the structures within 
both the anterior-to-posterior axis and the proximal-to-distal axis. The resultant 
phenotypes typically follow the expected spatio-temporal expression of HOX genes 
with more 3′ genes causing malformations in more anterior and proximal areas and 
more 5′ genes causing defects in more posterior, distal body segments and organs. 
For instance, Hoxa13 and Hoxd13 have been identified to be involved in endochon-
dral bone formation [24]. HOXD13 is mutated in synpolydactyly, and HOXA13 is 
mutated in Hand-Foot-Genital syndrome [22]. Overexpression of Hoxa13 affects 
the expression of Enpp2, an enzyme produced in precartilaginous condensations 
that modulates cell motility [25]. Loss-of-function of Hoxa13 was also reported to 
modulate expression of bone morphogenetic proteins like BMP2 and BMP7 [26]. 
Hoxa13 regulated expression of BMP2 and BMP7 was shown to control distal limb 
morphogenesis [27].
Temporal and spatial dynamic regulation of gene expression is a hallmark of 
developmental control genes, since they have to act locally in order to affect specific 
developmental processes [28]. By linking differentiation programs to specific cell 
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positions, selected cells can be programmed to develop similarly in a defined region. 
While spatial boundaries are first defined during embryonic development, these 
spatial patterns of cellular specialization also need to be maintained throughout 
adulthood as the tissues undergo continuous self-renewal.
4. Epigenetic regulation of HOX gene expression
Epigenetic mechanisms have an important role in the regulation of HOX gene 
expression in embryonic development and in differentiated cells. The established 
expression patterns of HOX genes must be precisely and clonally maintained 
throughout development. Epigenetic regulation of gene expression by chromatin 
structure is defined by a set of posttranslational modifications of histones, such as 
methylation, acetylation and phosphorylation. Furthermore, gene expression can 
be epigenetically regulated by DNA methylation.
In totipotent embryonic stem cells, HOX genes are silenced and then rapidly 
activated during embryogenesis. In drosophila and vertebrates, repressive Polycomb 
and Trithorax group complexes regulating histone methylation control the proper 
maintenance of HOX gene expression during this process [29]. Tight temporal and 
spatial control of HOX gene expression in this phase is essential. In vertebrates, 
dynamic changes in histone methylation are observed during the sequential activa-
tion of HOX genes in the embryo, suggesting that progressive change of epigenetic 
modifications regulate collinear gene activation in these loci [29]. Based on the 
presence of retinoic acid response elements (RAREs) in the regulatory region of 
many of the HOX genes, it was shown that that retinoic acid is a crucial factor in the 
epigenetic regulation of histone methylation of the clustered HOX genes [30].
Figure 1. 
The spatial organization of the Hox genes in the various genomic Hox clusters (Hox-A, Hox-B, Hox-C and 
Hox-D) is tightly linked to the pattern of their expression in the embryo (mouse embryo shown here). The same 
pattern of HOX gene expression that formed during embryonic development can still be found in stromal tissues 
(fibroblasts, endothelial cells) in the adult human body. The picture was taken from the course ‘Homeotic 
genes’ by the Khan Academy. Note: All Khan Academy content is available for free at www.khanacademy.org.
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During developmental stages, the genetic loci of the 4 HOX clusters carry 
so-called “bivalent chromatin tags”, like many other key developmental genes in 
embryonic stem cells [31]. This means that the HOX clusters possess at the same 
time “active” (i.e., trimethylation of histone 3 at lysine 4 -H3K4me3) and “inactive” 
(i.e., trimethylation of histone 3 at lysine 27 -H3K27me3) histone marks. In the pres-
ence of the right trans-acting factors, these bivalent tags can rapidly change to allow 
binding to cis-elements and initiation of transcription [32].
Epigenetic modifications also regulate tissue specific expression of HOX genes 
and mesenchymal cell differentiation [33]. In a study of genome-wide differential 
DNA methylation by reduced representation bisulfite sequencing (RRBS), the HOX 
gene clusters were highly overrepresented among the genes with hypermethylation 
in the skeletal muscle lineage [34]. Analysis of DNA methylation of HOX genes in 
myoblasts, myotubes and adult skeletal muscle tissue revealed that myogenic DNA 
hypermethylation of promoters and enhancers of HOX genes helps to fine-tune 
HOX gene expression in cellular differentiation [34].
HOX loci contain many noncoding transcripts. Long non-coding RNAs 
(lncRNAs) represent a class of noncoding RNAs that are longer than 200 nucleo-
tides without protein-coding potential. They have been found to function as master 
regulators of gene expression in health and in various human diseases. LncRNAs 
can regulate biological functions in cis and in trans [35]. For instance, they can 
recruit histone modifying enzymes to specific genomic sites and serve as scaffolds 
for gene expression modulating enzymes [36].
HOX antisense intergenic RNA (HOTAIR) is a lncRNA that is encoded in the 
HOXC locus and that mediates the placement of repressive H3K27me3 marks. 
HOTAIR expression has been shown to repress the expression of genes in the 3’ 
HOXD locus and thus was suggested to be an important epigenetic regulator of 
site-specific HOX expression during embryonic development [37]. However, these 
data is debated and the full role of HOTAIR in embryonic development is not yet 
understood [38].
HOXA transcript at the distal tip (HOTTIP) is a 3764 nucleotide lncRNA 
encoded from a genomic region in the 5′ tip of the HOXA locus, regulating the 
expression of HOXA13 [39]. By binding the adaptor protein WD repeat-containing 
protein 5 (WDR5) and interaction with mixed lineage leukemia (MLL), HOTTIP 
can catalyze methylation of histone H3 lysine K4 (H3K4). H3K4 methylation is asso-
ciated with increased gene transcription and MLL-WDR5 complexes were shown to 
occupy transcriptional start sites of various HOXA genes.
To date, the complex epigenetic patterns of cellular specialization in adult 
vertebrates and the mechanisms of their maintenance are not well understood. 
Epigenetic conservation of region-specific HOX gene expression in human adult 
fibroblasts suggests that they serve to maintain the differential patterns of the 
stroma during homeostasis and regeneration [40].
5. HOX gene expression in specific fibroblast populations
5.1 Skin fibroblasts
Epithelial tissues such as skin demonstrate remarkable anatomic differences 
leading to diversity on their structure and function. Genome-wide studies in skin 
fibroblasts demonstrated that site-specific HOX expression in these cells can define 
and maintain skin positional identity [41]. Analysis of genome-wide patterns of 
gene expression in cultured fetal and adult human skin fibroblasts at different 
anatomical sites showed distinct and characteristic site-specific transcriptional 
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patterns, suggesting that fibroblasts at different locations in the body possess 
specialized functions [7]. The maintenance of region-specific HOX gene expres-
sion in adult fibroblasts may serve as a source of positional memory for skin during 
homeostasis and regeneration.
For instance, HOXA13, a gene that is preferentially expressed at distal body 
parts such as hands and feet, remains essential for maintaining the distal-specific 
transcriptional program in adult fibroblasts by inducing the expression of WNT5A, 
which is crucial for distal organ development [41]. Furthermore, reduction of 
HOXA13 abrogates the ability of distal fibroblasts to produce epidermal keratin 9, a 
distal-specific gene. Keratin 9 has been shown to be important for maintaining the 
mechanical integrity of palmar and plantar skin [42]. Together these observations 
suggest that HOXA13-regulated gene expression in adult human fibroblasts provide 
the specific functions of plantar and palmar skin.
5.2 Synovial fibroblasts
Synovial fibroblasts are crucially involved in inflammation and joint destruction 
in chronic joint inflammation (arthritis) [43]. Synovial fibroblasts isolated from 
different joint locations show substantial differences in their transcriptome and 
function, in particular a site-specific HOX gene signature was found [44]. Adult 
human and mouse SFs from different anatomical locations exhibit joint-specific 
HOXA and HOXC signatures that are maintained over several passages in cell cul-
ture conditions, are arthritis independent and reproduced in whole synovial tissues.
This HOX gene signature was shown to be epigenetically imprinted by DNA 
methylation and histone modifications [44, 45]. The joint-specific HOX expression 
in mouse and human synovial fibroblasts and synovial tissues reflected the pat-
tern of HOX gene expression during embryonic limb development [44]. Only few 
studies explored the functional role of different HOX proteins in synovial fibro-
blasts. HOXD10 silencing downregulated the p38/c-Jun N-terminal kinase signaling 
pathway, and suppressed the migration of synovial fibroblasts [26]. HOXD9 was 
found to modulate proliferation of synovial fibroblasts [46]. During development 
of the distal limb mesenchyme, Hoxd13 is the most strongly expressed HoxD gene, 
with a progressive decline in expression levels of Hoxd12 to Hoxd9 [47]. Moreover, 
in tetrapods, coordinated expression of the 5′ located Hoxd genes is essential for the 
development of digits [48]. Thus, site-specific expression of HOXD genes in distal 
joints (hands and feet) [44] might influence the activation of pro-inflammatory 
pathways and the migratory and proliferative capacity of synovial fibroblasts. 
Notably, distal joints are the first and most severely affected joints in patients with 
rheumatoid arthritis (RA).
Other HOX genes may also play a critical role in the pathogenesis of RA. One 
study showed that basic fibroblast growth factor (bFGF) affects the expression and 
transcriptional regulation of HOXC4 and via this pathway promotes hyperplasia of 
the synovium in RA [49].
Several studies suggest epigenetic changes as determinants of a persistent 
activated phenotype of synovial fibroblasts in RA [43]. RA synovial fibroblasts 
display wide-spread changes in DNA methylation causing up-regulation of 
disease relevant genes such as growth factors, adhesion molecules and matrix-
metalloproteinases (MMPs) [50–52]. The tight epigenetic regulation of site-
specific HOX gene expression might thus be disturbed in RA synovial fibroblasts, 
leading to aberrant expression of HOX genes at sites where they are normally 
repressed. The expression of HOXD10 for instance was found to be higher in knee 
synovial fibroblasts from patients with rheumatoid arthritis (RA) compared to 
osteoarthritis (OA) [26].
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The lncRNA HOTTIP, encoded in the HOXA cluster, was shown to play a crucial 
role in the persistent activation of myofibroblasts promoting chronic inflamma-
tion and collagen deposition [53]. Silencing of HOTTIP reduced inflammation 
in a mouse model of arthritis and modified synovial fibroblast function by DNA 
demethylation of the locus encoding SFRP1 (Secreted Frizzled Related Protein 1), a 
modulator of the Wnt signaling pathway [54].
5.3 Gastrointestinal fibroblasts
The adult gastrointestinal tract was shown to keep the position-specific expres-
sion pattern of HOX genes along the anteroposterior axis of embryonic develop-
ment, recapitulating the expression pattern in the embryonic gastrointestinal tract 
[55]. HOX gene expression varied over 11 different measured gastrointestinal sites 
and clearly separated segments of the upper gastrointestinal tract from segments of 
the lower gastrointestinal tract. Accordingly, differences in HOX gene expression 
were found by comparing the gene expression profile of gastrointestinal fibro-
blasts isolated from the stomach, ileum and the colon. In particular, HOX paralogs 
with lower numbers (e.g. HOXA2, HOXD3) were preferentially expressed in the 
esophagus and stomach, while HOX paralogues with higher numbers (e.g. HOXA10, 
HOXD10) tended to be more expressed in the cecum and rectum. Using hierarchi-
cal clustering analysis, different subgroups of gastrointestinal fibroblasts were 
identified based on differences in transcriptional regulation, signaling ligands, and 
extracellular matrix remodeling [56].
Gastrointestinal fibroblasts play a pivotal role in gastrointestinal epithelial 
renewal by supporting epithelial cell differentiation, and they have been described 
to contribute to gastrointestinal inflammation and fibrosis [57, 58]. Furthermore, 
gastrointestinal fibroblasts are strongly involved in the initiation, progression 
and metastasis of gastrointestinal cancer [59]. For instance, increased expression 
of HOXA13, HOXB13 and HOXC13 was found in esophageal pathologies such as 
esophageal squamous cell cancer, Barrett’s esophagus or esophageal adenocarci-
noma [60, 61]. Aberrant expression these HOX paralogues, which are normally 
less expressed in upper gastrointestinal parts might contribute to the activation 
of pathogenic processes at this site. Together these observations suggest that HOX 
genes might play a role in steering position-specific processes during gut inflamma-
tion and cancer development [62]. Unfortunately, up to know functional studies are 
lacking that analyzed the impact of site-specific HOX expression on gut homeosta-
sis and disease development.
6. HOX genes in hematopoietic cells
Apart from stromal cells, HOX genes are expressed in hematopoietic stem cells 
and progenitors in early development, with a pattern characteristic of the lineage 
and stage of differentiation of the cell. Using gene targeting technology and gain-
of-function and loss-of-function mutations, the function of HOX genes in hemato-
poiesis has been extensively investigated [63].
For example, HOXB3, HOXB4 and HOXA9 are highly expressed in uncommit-
ted hematopoietic cells, whereas HOXB8 and HOXA10 are expressed in myeloid 
committed cells. The different HOX clusters also have specific patterns of lineage-
restricted expression, whereby HOXA genes are expressed in myeloid cells, HOXB 
genes in erythroid cells and HOXC genes in lymphoid cells. Intriguingly, the HOXD 
genes are not expressed in hematopoiesis despite having similar regulatory regions 
to the other clusters [64–66].
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These observations indicate that modulation of the expression of a particular 
HOX gene can alter cell phenotype and suggest a causal relationship for lineage-
specific patterns of HOX gene expression [67].
7. HOX genes in disease
7.1 HOX genes in cardiovascular disease
Steadily increasing evidence supports the idea that gene expression diversities in 
the vascular system are a major contributing factor in determining region-specific 
cardiovascular disease susceptibility. The regionally distinct and topographic expres-
sion patterns of HOX transcription factors in embryonic development is remembered 
in vascular smooth muscle cells [68] as well as in endothelial cells [7, 18, 69]. The 
persistent topographic expression patterns in post-natal vascular tissues suggest that 
HOX genes play a critical role in maintaining vessel wall homeostasis in a region-
specific manner [70]. Intriguingly, in adult mice, high-throughput mRNA profiling 
revealed that HOX paralogues 6-10 (Hox6-10) are higher expressed in the thoracic 
aorta, which is resistant to atherosclerotic lesions, than in the aortic arch, which is 
highly athero-susceptible [68]. In humans, the differential expression of HOXA9 gene 
contributed to phenotypic differences in smooth muscle cells from athero-resistant 
compared athero-susceptible regions, which might be connected to the site-specific 
development of atherosclerotic plaques. For example, region-specific reciprocal 
interactions of HOXA9 with the pro-inflammatory transcription factor NF-κB have 
been demonstrated. In general, genetic regulatory networks of cardiovascular diseases 
processes implicated genes of various functional categories such as ECM remodeling, 
transmembrane signaling, cell cycle control, and inflammatory response as poten-
tially HOX-dependent.
Ectopic activation of HOXC10 and HOXC9 in atherosclerotic coronary arteries 
has been found to be associated with loss of DNA methylation within the HOXC11/
HOXC9 genomic interval [34, 71]. These data define epigenetic mechanisms con-
trolling HOX expression as critical in aberrant expression of HOX and HOX-target 
genes in cardiovascular disease [72].
7.2 HOX genes in solid cancers
In embryogenesis, a fine balance between cell proliferation and differentiation 
is essential for normal development of the fetus, but in cancer, the balance between 
the two processes is impaired [63, 73].
Studies suggest that the expression of HOX genes becomes dysregulated dur-
ing development of various solid tumors, including colon, breast, prostate, lung, 
glioblastomas, thyroid, bladder, ovarian, melanoma, and kidney cancers [74, 75]. In 
fact, the specific pattern of change in HOX gene expression is dependent on cancer 
type, tumor stage, and, in certain cases, on anatomic location [76].
HOX genes have been identified to be important regulators of cancer stem cells 
(CSCs) which are critical for initiation and progression of solid tumors [33, 74]. 
These genes act as transcriptional activators as well as transcriptional repressors 
in cancers [77]. Studies show that the expression of specific HOX genes in can-
cers tends to differ based on tissue type and tumor site. HOXA genes were often 
reported to have altered expression in breast and ovarian cancers, HOXB genes in 
colon cancers, HOXC genes in prostate and lung cancer and HOXD genes in colon 
and breast cancers. This pattern can be linked to the embryonic origin of tissues. For 
example, colon, prostate, and lung, originating from endodermal, showed relatively 
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similar HOXA and HOXB family gene expression patterns compared to breast 
tumors arising from mammary tissue, which originates from the ectoderm [74].
The differential expression of HOX genes in various solid tumors provides an 
opportunity to advance our understanding of cancer development and to develop 
new therapeutic agents. Specific methylation profiles in HOX clusters or in HOX-
associated histones are recognized as potential biomarkers in several cancers and 
can be exploited in cancer therapy. The use of epigenetic drugs affecting general-
ized or specific DNA methylation profiles is a promising approach in cancer therapy 
in the near future. However, since the generalized effect of epigenetic drugs may 
lead to secondary malignancies, the development of drugs targeting specific 
epigenetic alterations, including those related to HOX genes, could advance this 
therapeutic approach [78].
HOX genes are recognized as potential therapeutic targets in adrenocortical 
tumors. Understanding the pathway being regulated by the transcription factor 
HOXB9, which promotes adrenal tumor progression through an increase in the 
expression of cell cycle genes, including Ccne1, could help to development potential 
drug targets for adrenocortical carcinoma [79]. Moreover, HOX peptide inhibitor 
showed a promising effect on cell survival in mice and could be used as peptide-
based cancer therapeutics [80].
Analyses of HOX gene expression in normal breast tissue and primary breast 
cancers [81] showed that several HOX genes are differentially expressed in breast 
cancer compared to normal breast tissues, with different breast cancer tissues and 
cell lines showing high variability in the pattern of HOX gene expression [81]. Thus, 
these studies support the idea that aberrant expression of HOX genes is involved 
in the development of breast cancer and in the malignant behavior of cancer cells, 
but shows that, at least in breast cancer, there is no uniform pattern of HOX gene 
alterations that lead to malignant growth of cells.
The stroma surrounding solid tumors is built from cancer-associated fibro-
blasts (CAFs) which are recognized to play a significant role in tumor growth. 
Interestingly, it could be shown that CAFs predominantly develop from local 
fibroblasts at the site of the tumor [82]. Therefore, site-specific differences in local 
fibroblasts surrounding the tumor might be crucially involved in tumor develop-
ment and invasiveness. Furthermore, site-specific differences in fibroblasts might 
be connected to the site-specific distribution of cancer metastases in certain organs 
[83]. This would support the “seed and soil” hypothesis, which states that the 
distribution pattern of metastases is highly dependent on the microenvironment 
of the organ in which the metastases are located [84]. Unfortunately, an analysis of 
the expression and influence of HOX genes in CAFs from different tumor sites is 
missing up to now.
7.3 HOX genes in joint and bone disease
Mammalian HOX genes are critical for proper development of skeletal morphol-
ogy during embryogenesis. The continuous function of HOX genes in the skeleton 
after the establishment of skeletal morphology has been determined using genetic 
tools in mouse models [85]. The generation of a conditional Hoxd11 allele that can 
be deleted at adult stages after normal development and growth of the skeleton 
was used to show that Hox genes in the adult skeleton regulate the differentiation 
of skeletal stem cells into bone cells [86]. These data convincingly showed that Hox 
gene function in the skeleton is not restricted to development and that Hox genes 
play a crucial, functional role in adult bone homeostasis.
Furthermore, functional importance of Hox genes in the regulation of chondro-
cyte differentiation has been demonstrated [85, 87]. Hox genes are involved in the 
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regulation of the progression of cells along the chondrogenic differentiation path-
way after the initial formation of the cartilage anlagen. However, overexpression of 
a Hoxc8 transgene caused cartilage defects whose severity depended on the dosage 
of the transgene [85]. The abnormal cartilage was characterized by an accumulation 
of proliferating chondrocytes and reduced maturation. These results suggest that 
Hoxc8 continues to regulate cartilage homeostasis after development, presum-
ably by controlling the progression of cells along the chondrocyte differentiation 
pathway. Their capacity for regulation of cartilage differentiation suggests that 
HOX genes could also be involved in human chondrodysplasias or other cartilage 
disorders [85].
Arthritic joints are characterized by rearrangements and dysregulated gene 
expression of bone, cartilage and synovial tissues [88, 89]. The exact molecular and 
cellular events leading to the development of the different kinds of arthritis still 
remain elusive, but involvement of HOX gene regulation in the key tissues affected 
by rheumatic muscular-skeletal diseases indicate a potential link between arthritis 
development and HOX transcription factors. HOX genes were for instance associ-
ated with the onset and development of osteoarthritis (OA) (e.g. HOXA9 in hip 
OA) and as mentioned above with pathogenic important joint-specific functions 
of synovial fibroblasts in RA [45, 90, 91]. However, it has not been clarified up to 
know whether changes of expression of HOX genes in OA are specific for a specific 
joint region or a common feature of disease.
Like a number of human diseases, rheumatic diseases include characteristic 
pathologies in specific anatomical locations [21, 44]. For example, ankylosing 
spondylitis is a chronic inflammatory disease affecting the spinal vertebrae and 
sacroiliac joints, causing debilitating pain and loss of mobility [92]. Joints in the 
hands, are commonly involved in RA and OA [93]. Reactive arthritis is a rheumatic 
condition that causes inflammation particularly in knees [94]. Several mechanisms 
might be involved in this susceptibility of specific joints for developing specific 
forms of arthritis. In addition to and maybe in combination with local mechanic 
factors, site-specific gene expression of local cell types (bone, cartilage, synovium), 
potentially regulated by HOX genes, might be crucially involved in the development 
of specific arthritides in specific joint locations. Furthermore, disease-specific 
systemic triggers, such as specific auto-antibodies or cytokines might preferentially 
affect local cell types at a specific anatomic sites [95].
8. Conclusions
HOX genes, a family of homeodomain transcription factors, guide embryonic 
development by encoding positional information during axis formation, determin-
ing site specificity of the body plan and regulating formation of structures along the 
various body axes.
Like other transcription factors, HOX genes control the establishment and 
maintenance of specific cell states by regulating distinct sets of downstream genes. 
Despite their similar DNA-binding properties, they have highly specific effects on 
the transcriptome. This genetic control results in functional diversity of various 
body parts. Cells such as fibroblasts thus develop not only an organ-specific but also 
a site-specific transcriptional program. Intriguingly, these HOX regulated tran-
scriptional programs are epigenetically maintained in adult cells.
Several studies endorse that regulation of site-specific gene expression by HOX 
genes contribute to the development of a broad range of diseases (Figure 2). The 
site-specific environment created by the expression of specific HOX genes might 
promote or prevent the development of diseases at specific locations, in line with 
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the ‘seed and soil’ hypothesis. Furthermore, activation or repression of HOX 
expression during disease development, potentially by modulation of the epigenetic 
mechanisms regulating the HOX loci, might further influence site-specific disease 
processes.
Therefore, a better understanding of site-specific cellular and molecular mecha-
nisms underlying regional appearance of disease is essential for understanding 
disease development and designing new therapeutic approaches.
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Figure 2. 
Summary of diseases that have been associated with HOX gene expression. In some cases (blue letters) regular 
site-specific expression of HOX genes has been connected to disease development based on the functions of the 
respective HOX genes (below in italics). In other cases, aberrant expression of HOX genes (red letters) was 
associated with the development of diseases (below in italics). SF = synovial fibroblasts. The figure was created 
with Biorender.
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